Yifeng Pharmacy Market Cap ($4.80 Billion)
Market Cap & Net Worth: Yifeng Pharmacy (603939)
Yifeng Pharmacy market cap. Yifeng Pharmacy (SHG:603939) has a market capitalization of $4.80 Billion (CN¥32.82 Billion) as of November 8, 2026. Listed on the SHG stock exchange, this China-based company holds position #3558 globally and #456 in its home market, demonstrating a 7.42% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Yifeng Pharmacy's stock price CN¥27.07 by its total outstanding shares 1212391959 (1.21 Billion). Also see Yifeng Pharmacy operating cash flow efficiency for how efficiently the company converts equity into cash flow.
Yifeng Pharmacy Market Cap History (2015–2026)
Yifeng Pharmacy market cap history from 2015 to 2026. Data shows growth from $2.81 Billion to $4.80 Billion (5.61% CAGR). Check current stock price of Yifeng Pharmacy for real-time trading data and today's change.
Yifeng Pharmacy Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Yifeng Pharmacy's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Yifeng Pharmacy net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.18x
Yifeng Pharmacy's market cap is 0.18 times its annual revenue
Latest Price to Earnings (P/E) Ratio
2.80x
Yifeng Pharmacy's market cap is 2.80 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $2.81 Billion | $2.85 Billion | $175.94 Million | 0.99x | 15.95x |
| 2016 | $1.97 Billion | $3.73 Billion | $223.89 Million | 0.53x | 8.80x |
| 2017 | $3.05 Billion | $4.81 Billion | $313.50 Million | 0.63x | 9.73x |
| 2018 | $2.81 Billion | $6.91 Billion | $416.41 Million | 0.41x | 6.75x |
| 2019 | $4.96 Billion | $10.28 Billion | $543.75 Million | 0.48x | 9.13x |
| 2020 | $8.60 Billion | $13.14 Billion | $743.52 Million | 0.65x | 11.56x |
| 2021 | $6.86 Billion | $15.33 Billion | $887.88 Million | 0.45x | 7.73x |
| 2022 | $8.00 Billion | $19.89 Billion | $1.26 Billion | 0.40x | 6.34x |
| 2023 | $7.10 Billion | $22.59 Billion | $1.41 Billion | 0.31x | 5.03x |
| 2024 | $4.28 Billion | $24.06 Billion | $1.53 Billion | 0.18x | 2.80x |
Competitor Companies of 603939 by Market Capitalization
Companies near Yifeng Pharmacy in the global market cap rankings as of November 8, 2026. Also see 603939 total asset value for a full breakdown of the balance sheet.
Key companies related to Yifeng Pharmacy by market ranking:
- JD HEALTH INTL LTD (F:8ZN): Ranked #1887 globally with a market cap of $12.04 Billion USD ( €10.30 Billion EUR).
- Walgreens Boots Alliance Inc (NASDAQ:WBA): Ranked #2107 globally with a market cap of $10.37 Billion USD.
- Dashenlin Pharm Grp Co Ltd (SHG:603233): Ranked #4274 globally with a market cap of $3.58 Billion USD ( CN¥24.47 Billion CNY).
- Clicks (JSE:CLS): Ranked #5006 globally with a market cap of $2.73 Billion USD ( ZAC5.14 Trillion ZAC).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1887 | JD HEALTH INTL LTD | F:8ZN | $12.04 Billion | €4.87 |
| #2107 | Walgreens Boots Alliance Inc | NASDAQ:WBA | $10.37 Billion | $11.98 |
| #4274 | Dashenlin Pharm Grp Co Ltd | SHG:603233 | $3.58 Billion | CN¥21.49 |
| #5006 | Clicks | JSE:CLS | $2.73 Billion | ZAC22000.00 |
Market Capitalization of Yifeng Pharmacy (2015–2026)
Market capitalization of Yifeng Pharmacy from 2015 to today. Between 2015 and today, Yifeng Pharmacy's market cap moved from $2.81 Billion to $ 4.80 Billion, with a yearly change of 5.61%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥4.80 Billion | +24.63% |
| 2025 | CN¥3.85 Billion | -9.99% |
| 2024 | CN¥4.28 Billion | -39.74% |
| 2023 | CN¥7.10 Billion | -11.16% |
| 2022 | CN¥8.00 Billion | +16.53% |
| 2021 | CN¥6.86 Billion | -20.19% |
| 2020 | CN¥8.60 Billion | +73.22% |
| 2019 | CN¥4.96 Billion | +76.49% |
| 2018 | CN¥2.81 Billion | -7.85% |
| 2017 | CN¥3.05 Billion | +54.94% |
| 2016 | CN¥1.97 Billion | -29.81% |
| 2015 | CN¥2.81 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 8th, 2026 the market cap of Yifeng Pharmacy was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.80 Billion USD |
| MoneyControl | $4.80 Billion USD |
| MarketWatch | $4.80 Billion USD |
| marketcap.company | $4.80 Billion USD |
| Reuters | $4.80 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Yifeng Pharmacy
Yifeng Pharmacy Chain Co., Ltd. engages in the retail business of pharmaceutical products in China. The company operates through Retail business and Wholesale business segments. It offers Western and Chinese patent medicine, traditional Chinese medicine herbal pieces, medical devices and equipment, health supplements and products, personal care products, drugs, and convenience products related to… Read more